Furthermore, centralized validation studies involving multi-institutional cohorts would help to assess the reproducibility of TRPS1 staining in different tumor contexts, ensuring that TRPS1 can be reliably used as a diagnostic marker beyond breast carcinoma. The gene discussed is TRPS1; the disease is breast carcinoma.